143 results on '"Kozielewicz, Dorota"'
Search Results
2. The association of airborne particulate matter and benzo[a]pyrene with the clinical course of COVID-19 in patients hospitalized in Poland
3. Hepatitis C Infection Is Not a Cardiovascular Risk Factor in Young Adults.
4. Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study.
5. Change in the Clinical Picture of Hospitalized Patients with COVID-19 between the Early and Late Period of Dominance of the Omicron SARS-CoV-2 Variant
6. Short‐term exposure to ambient air pollution and COVID‐19 severity during SARS‐CoV‐2 Delta and Omicron waves: A multicenter study
7. Effectiveness and safety of ledipasvir/sofosbuvir ± ribavirin in the treatment of HCV infection: The real-world HARVEST study
8. Retrospective Analysis of the Effectiveness of Remdesivir in COVID-19 Treatment during Periods Dominated by Delta and Omicron SARS-CoV-2 Variants in Clinical Settings
9. Clinical evidence of the effectiveness of remdesivir in COVID-19 during periods dominated by Delta and Omicron SARS-CoV-2 variants.
10. Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
11. The Course of COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases
12. Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
13. Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy
14. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of February 23, 2022
15. Demographic and Clinical Overview of Hospitalized COVID-19 Patients during the First 17 Months of the Pandemic in Poland
16. Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study
17. Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study
18. Impact of Kidney Failure on the Severity of COVID-19
19. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021
20. Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6
21. Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis
22. Liver abscesses – from diagnosis to treatment
23. Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study
24. Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter Study
25. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020
26. Annex #1 as of 8 June 2020 to: Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020
27. Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists
28. Liver abscesses - from diagnosis to treatment.
29. Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study.
30. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020.
31. Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4
32. Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis
33. Prophylaxis of vertical HBV infection
34. Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
35. Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta
36. Renal impairment in patients with chronic hepatitis C treated with first generation protease inhibitors
37. Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis
38. The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C
39. Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?
40. Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4
41. Virological response to treatment with peginterferon alfa-2a in adolescents with chronic hepatitis B.
42. Stłuszczenie wątroby u pacjentów zakażonych HCV
43. Wybrane aspekty kliniczne nadużywania alkoholu
44. Interferon-induced thyroiditis during treatment of chronic hepatitis C.
45. Agranulocytosis during treatment of chronic hepatitis C complicated by hyperthyreosis. Case reports.
46. Demographic and Clinical Overview of Hospitalized COVID-19 Patients during the First 17 Months of the Pandemic in Poland.
47. Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter Study.
48. Is spontaneus recovery from HCV infection more often?
49. Diagnosis and therapy of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of November 12, 2021. Annex no. 1 to the Recommendations of April 26, 2021.
50. Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 1 as of June 8, 2020.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.